Zynerba Pharmaceuticals, Inc. short interest in 2023
In 2023, Zynerba Pharmaceuticals, Inc.'s disclosed short interest ran from 0.51% of shares outstanding on 15 Mar 2023 to 0.12% on 15 Aug 2023, a change of -0.39 percentage points. The year's high was 0.51% on 15 Mar 2023 and its low 0.08% on 31 Jul 2023, averaging 0.21% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.14 days on 14 Apr 2023. Full history: Zynerba Pharmaceuticals, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2023 in figures
- Start of year
- 0.51% (15 Mar 2023)
- End of year
- 0.12% (15 Aug 2023)
- Change
- -0.39 pp
- High
- 0.51% (15 Mar 2023)
- Low
- 0.08% (31 Jul 2023)
- Average
- 0.21%
- Highest days to cover
- 1.14 (14 Apr 2023)
- SEC filings marked
- 5
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Mar 2023 | 0.51% | 1.00 | |
| 31 Mar 2023 | 0.33% | 1.00 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 0.34% | 1.14 | |
| 28 Apr 2023 | 0.17% | 1.00 | |
| 15 May 2023 | 0.16% | 1.00 | 10-Q filed, results (8-K) |
| 31 May 2023 | 0.15% | 1.00 | |
| 15 Jun 2023 | 0.09% | 1.00 | |
| 14 Jul 2023 | 0.16% | 1.00 | |
| 31 Jul 2023 | 0.08% | 1.00 | |
| 15 Aug 2023 | 0.12% | 1.00 | 10-Q filed |
See also: Zynerba Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.